Advertisement

Investing $1,000 in These 2 Psychedelic Stocks Is an Absurdly Smart Move

Investing $1,000 in These 2 Psychedelic Stocks Is an Absurdly Smart Move

There's another upcoming opportunity that's shaping up to be even bigger: psychedelics. As outlandish as taking LSD or psychedelic mushrooms for their therapeutic effects may seem, these budding psychedelic medicines have the potential to revolutionize mental healthcare. Compass Pathways (NASDAQ: CMPS) is one of the psychedelic therapy industry's key influencers, and it also has the makings of a growth stock par excellence.